|
Hikma Pharmaceuticals knows the right prescription for a healthy bottom line. The company makes nearly 200 branded and unbranded generic drugs, which are available in a variety of forms and dosage strengths. It also sells about 20 patent-protected products through licensing agreements with other pharmaceutical companies. Hikma's products are distributed to doctors, hospitals, and pharmacies in more than 40 nations in North America, Europe, the Middle East, and Africa through its network of sales representatives. The company conducts research and development in areas such as metabolism, anti-infective, and central nervous system therapies. Hikma Pharmaceuticals was founded in 1978 by Chairman Samih Darwazah.
|
| | | Contact Information | |
Address: |
13 Hanover Square
London W1S 1HW, United Kingdom
| | Phone: | +44-20-7399-2760 | | Fax: | +44-20-7399-2761 |
|
| Financial
Highlights | | Fiscal Year End: | September | | Revenue (2008): | 576.30 M | | Revenue Growth (1 yr): | 29.10% |
|
|
Key People
| | • |
Chairman:
Samih Darwazah
| | • |
CEO:
Said Darwazah
| | • |
CFO:
Bassam Kanaan
|
|
|
